New Key Statistics Module, Z-Score and F-Score
NAS:CPRX Key Ratios
| Market Cap $ M | 1,761.89 |
| Enterprise Value $ M | 1,650.83 |
| P/E(ttm) | 24.48 |
| PE Ratio without NRI | 24.48 |
| Forward PE Ratio | 10.22 |
| Price/Book | 4.12 |
| Price/Sales | 4.21 |
| Price/Free Cash Flow | 28.51 |
| Price/Owner Earnings | 136.93 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 398.00 |
| EPS (TTM) $ | 0.61 |
| Beneish M-Score | 0.1 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 13.70 |
| EV-to-EBIT | 19.02 |
| EV-to-EBITDA | 13.79 |
| PEG | -- |
| Shares Outstanding M | 118.01 |
| Net Margin (%) | 17.93 |
| Operating Margin % | 21.80 |
| Pre-tax Margin (%) | 23.73 |
| Quick Ratio | 2.68 |
| Current Ratio | 2.88 |
| ROA % (ttm) | 16.92 |
| ROE % (ttm) | 20.45 |
| ROIC % (ttm) | 32.93 |
| Dividend Yield % | -- |
| Altman Z-Score | 15.25 |
| Piotroski F-Score | 7.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | N |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | Y |
| Gross Margin Increase y-y | Y |
| Higher Asset Turnover y-y | Y |
CPRX Number of Guru Trades
CPRX Volume of Guru Trades
Gurus Latest Trades with NAS:CPRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CPRX is held by these investors
Total 2
Catalyst Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:CPRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers